Pacific Biosciences Of California (PACB) Other Gross PP&E Adjustments (2011 - 2026)

Pacific Biosciences Of California has reported Other Gross PP&E Adjustments for 16 years, with the latest figure at -$43.9 million in Q1 2026.

• For the quarter ending Q1 2026, Other Gross PP&E Adjustments rose 7.5% year-over-year to -$43.9 million; the trailing twelve-month figure through Mar 2026 stood at -$43.9 million (up 7.5% YoY), and the FY2025 full-year result was $60.1 million, down 23.06% from the prior year.
• Other Gross PP&E Adjustments for Q1 2026 stood at -$43.9 million, down from $60.1 million in the prior quarter.
• The five-year high for Other Gross PP&E Adjustments was $78.2 million in Q4 2024, with the low at -$51.2 million in Q1 2024.
• Average Other Gross PP&E Adjustments over 5 years is -$17.2 million, with a median of -$41.5 million recorded in 2023.
• Peak annual rise in Other Gross PP&E Adjustments reached 69.38% in 2022, while the deepest fall reached 130.72% in 2022.
• Tracing PACB's Other Gross PP&E Adjustments over 5 years: stood at $49.7 million in 2022, then advanced by 20.85% to $60.0 million in 2023, then surged by 30.17% to $78.2 million in 2024, then decreased by 23.06% to $60.1 million in 2025, then slumped by 173.0% to -$43.9 million in 2026.
• The last three Other Gross PP&E Adjustments figures came in at -$43.9 million (Q1 2026), $60.1 million (Q4 2025), and -$43.6 million (Q3 2025), per Business Quant data.

Peer Comparison